All In MedTech

FDA Clearance Tracker · P180027-S013

Flow Re-Direction Endoluminal Device (FRED®) System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 2, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P180027-S013
Device name
Flow Re-Direction Endoluminal Device (FRED®) System
Applicant location
Aliso Viejo, CA
Received
May 8, 2025
Decided
Nov 2, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P180027

Device type

Device class
Class III

Every decision under product code OUT

FDA's approval statement

As written in FDA's record.

Approval for the addition of the stent surface functionalization manufacturing process and to perform stent pusher loading, packaging, labeling, and sterilization on the FRED X system at the MicroVention Costa Rica manufacturing site located at Zona Franca Coyol Alajuela, Costa Rica.

Source documents

Other decisions for MicroVention, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.